Cargando…

Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9 Are Inversely Associated with N-Terminal Pro B-Type Natriuretic Peptide in Older Men and Women

Background and Aims: Cardiac natriuretic peptides (NPs) exert several metabolic effects, including some on lipid metabolism. Higher NPs levels are likely to be associated with a favorable lipid profile. In in vitro studies, NPs have been found to modulate low-density lipoprotein receptor (LDLR) traf...

Descripción completa

Detalles Bibliográficos
Autores principales: Spannella, Francesco, Giulietti, Federico, Galeazzi, Roberta, Passarelli, Anna, Re, Serena, Di Pentima, Chiara, Allevi, Massimiliano, Magni, Paolo, Sarzani, Riccardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405766/
https://www.ncbi.nlm.nih.gov/pubmed/36009507
http://dx.doi.org/10.3390/biomedicines10081961
_version_ 1784773957687181312
author Spannella, Francesco
Giulietti, Federico
Galeazzi, Roberta
Passarelli, Anna
Re, Serena
Di Pentima, Chiara
Allevi, Massimiliano
Magni, Paolo
Sarzani, Riccardo
author_facet Spannella, Francesco
Giulietti, Federico
Galeazzi, Roberta
Passarelli, Anna
Re, Serena
Di Pentima, Chiara
Allevi, Massimiliano
Magni, Paolo
Sarzani, Riccardo
author_sort Spannella, Francesco
collection PubMed
description Background and Aims: Cardiac natriuretic peptides (NPs) exert several metabolic effects, including some on lipid metabolism. Higher NPs levels are likely to be associated with a favorable lipid profile. In in vitro studies, NPs have been found to modulate low-density lipoprotein receptor (LDLR) trafficking by preventing proprotein convertase subtilisin/kexin type 9 (PCSK9) overexpression. The aim of our study is to investigate a possible association between plasma levels of PCSK9 and N-terminal pro B-type natriuretic peptide (NT-proBNP) in vivo. Methods: We performed a cross-sectional study on 160 consecutive older male and female patients hospitalized for medical conditions. Patients taking lipid-lowering drugs and patients with an admission diagnosis of acute heart failure were excluded. Fasting blood samples were collected after clinical stabilization of the acute illness, the day before discharge. Results: The mean age was 87.8 ± 6.4 years with a female prevalence (62.5%). The median NT-proBNP was 2340 (814–5397) pg/mL. The mean plasma PCSK9 was 275.2 ± 113.2 ng/mL. We found an inverse correlation between plasma PCSK9 and NT-proBNP (r = −0.280; p = 0.001). This association was confirmed after taking into account NT-proBNP tertiles (plasma PCSK9 levels: 317.4 ± 123.6 ng/mL in the first tertile, 283.3 ± 101.8 ng/mL in the second tertile, 231.3 ± 99.0 ng/mL in the third tertile, p = 0.001) and even after an adjustment for confounding factors (beta = −0.361, p = 0.001 for ln(NT-proBNP); beta = −0.330, p = 0.001 for NT-proBNP tertiles). The strength of the correlation between plasma PCSK9 and NT-proBNP was likely greater in patients affected by type 2 diabetes mellitus (r = −0.483; p = 0.006) and in male patients (r = −0.431, p = 0.001). Conclusion: The inverse association found between PCSK9 and NT-proBNP plasma levels in our real-life clinical study supports the hypothesis that NPs may play a role in cholesterol metabolism, possibly through an inhibitory action on circulating PCSK9 concentrations, thus increasing the availability of LDLR.
format Online
Article
Text
id pubmed-9405766
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94057662022-08-26 Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9 Are Inversely Associated with N-Terminal Pro B-Type Natriuretic Peptide in Older Men and Women Spannella, Francesco Giulietti, Federico Galeazzi, Roberta Passarelli, Anna Re, Serena Di Pentima, Chiara Allevi, Massimiliano Magni, Paolo Sarzani, Riccardo Biomedicines Article Background and Aims: Cardiac natriuretic peptides (NPs) exert several metabolic effects, including some on lipid metabolism. Higher NPs levels are likely to be associated with a favorable lipid profile. In in vitro studies, NPs have been found to modulate low-density lipoprotein receptor (LDLR) trafficking by preventing proprotein convertase subtilisin/kexin type 9 (PCSK9) overexpression. The aim of our study is to investigate a possible association between plasma levels of PCSK9 and N-terminal pro B-type natriuretic peptide (NT-proBNP) in vivo. Methods: We performed a cross-sectional study on 160 consecutive older male and female patients hospitalized for medical conditions. Patients taking lipid-lowering drugs and patients with an admission diagnosis of acute heart failure were excluded. Fasting blood samples were collected after clinical stabilization of the acute illness, the day before discharge. Results: The mean age was 87.8 ± 6.4 years with a female prevalence (62.5%). The median NT-proBNP was 2340 (814–5397) pg/mL. The mean plasma PCSK9 was 275.2 ± 113.2 ng/mL. We found an inverse correlation between plasma PCSK9 and NT-proBNP (r = −0.280; p = 0.001). This association was confirmed after taking into account NT-proBNP tertiles (plasma PCSK9 levels: 317.4 ± 123.6 ng/mL in the first tertile, 283.3 ± 101.8 ng/mL in the second tertile, 231.3 ± 99.0 ng/mL in the third tertile, p = 0.001) and even after an adjustment for confounding factors (beta = −0.361, p = 0.001 for ln(NT-proBNP); beta = −0.330, p = 0.001 for NT-proBNP tertiles). The strength of the correlation between plasma PCSK9 and NT-proBNP was likely greater in patients affected by type 2 diabetes mellitus (r = −0.483; p = 0.006) and in male patients (r = −0.431, p = 0.001). Conclusion: The inverse association found between PCSK9 and NT-proBNP plasma levels in our real-life clinical study supports the hypothesis that NPs may play a role in cholesterol metabolism, possibly through an inhibitory action on circulating PCSK9 concentrations, thus increasing the availability of LDLR. MDPI 2022-08-12 /pmc/articles/PMC9405766/ /pubmed/36009507 http://dx.doi.org/10.3390/biomedicines10081961 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Spannella, Francesco
Giulietti, Federico
Galeazzi, Roberta
Passarelli, Anna
Re, Serena
Di Pentima, Chiara
Allevi, Massimiliano
Magni, Paolo
Sarzani, Riccardo
Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9 Are Inversely Associated with N-Terminal Pro B-Type Natriuretic Peptide in Older Men and Women
title Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9 Are Inversely Associated with N-Terminal Pro B-Type Natriuretic Peptide in Older Men and Women
title_full Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9 Are Inversely Associated with N-Terminal Pro B-Type Natriuretic Peptide in Older Men and Women
title_fullStr Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9 Are Inversely Associated with N-Terminal Pro B-Type Natriuretic Peptide in Older Men and Women
title_full_unstemmed Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9 Are Inversely Associated with N-Terminal Pro B-Type Natriuretic Peptide in Older Men and Women
title_short Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9 Are Inversely Associated with N-Terminal Pro B-Type Natriuretic Peptide in Older Men and Women
title_sort plasma levels of proprotein convertase subtilisin/kexin type 9 are inversely associated with n-terminal pro b-type natriuretic peptide in older men and women
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405766/
https://www.ncbi.nlm.nih.gov/pubmed/36009507
http://dx.doi.org/10.3390/biomedicines10081961
work_keys_str_mv AT spannellafrancesco plasmalevelsofproproteinconvertasesubtilisinkexintype9areinverselyassociatedwithnterminalprobtypenatriureticpeptideinoldermenandwomen
AT giuliettifederico plasmalevelsofproproteinconvertasesubtilisinkexintype9areinverselyassociatedwithnterminalprobtypenatriureticpeptideinoldermenandwomen
AT galeazziroberta plasmalevelsofproproteinconvertasesubtilisinkexintype9areinverselyassociatedwithnterminalprobtypenatriureticpeptideinoldermenandwomen
AT passarellianna plasmalevelsofproproteinconvertasesubtilisinkexintype9areinverselyassociatedwithnterminalprobtypenatriureticpeptideinoldermenandwomen
AT reserena plasmalevelsofproproteinconvertasesubtilisinkexintype9areinverselyassociatedwithnterminalprobtypenatriureticpeptideinoldermenandwomen
AT dipentimachiara plasmalevelsofproproteinconvertasesubtilisinkexintype9areinverselyassociatedwithnterminalprobtypenatriureticpeptideinoldermenandwomen
AT allevimassimiliano plasmalevelsofproproteinconvertasesubtilisinkexintype9areinverselyassociatedwithnterminalprobtypenatriureticpeptideinoldermenandwomen
AT magnipaolo plasmalevelsofproproteinconvertasesubtilisinkexintype9areinverselyassociatedwithnterminalprobtypenatriureticpeptideinoldermenandwomen
AT sarzaniriccardo plasmalevelsofproproteinconvertasesubtilisinkexintype9areinverselyassociatedwithnterminalprobtypenatriureticpeptideinoldermenandwomen